These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2372968)

  • 1. Ranitidine cross-reactivity in the EMIT d.a.u. Monoclonal Amphetamine/Methamphetamine Assay.
    Kelly KL
    Clin Chem; 1990 Jul; 36(7):1391-2. PubMed ID: 2372968
    [No Abstract]   [Full Text] [Related]  

  • 2. Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Poklis A; Hall KV; Still J; Binder SR
    J Anal Toxicol; 1991; 15(2):101-3. PubMed ID: 2051743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine interference with standard amphetamine immunoassay.
    Liu L; Wheeler SE; Rymer JA; Lower D; Zona J; Peck Palmer OM; Tamama K
    Clin Chim Acta; 2015 Jan; 438():307-8. PubMed ID: 25242739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine/methamphetamine assay.
    Grinstead GF
    Clin Chem; 1989 Sep; 35(9):1998-9. PubMed ID: 2673588
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible explanation for trimethobenzamide cross-reaction in immunoassays of amphetamine/methamphetamine.
    Colbert DL
    Clin Chem; 1994 Jun; 40(6):948-9. PubMed ID: 8087994
    [No Abstract]   [Full Text] [Related]  

  • 6. Reagent lot-to-lot variability in sensitivity for amphetamine with the Syva Emit II Monoclonal Amphetamine/Methamphetamine assay.
    Singh J
    J Anal Toxicol; 1997; 21(2):174-5. PubMed ID: 9083839
    [No Abstract]   [Full Text] [Related]  

  • 7. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay.
    Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K
    Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unavailability of drug metabolite reference material to evaluate false-positive results for monoclonal EMIT-d.a.u. assay of amphetamine.
    Poklis A
    Clin Chem; 1992 Dec; 38(12):2560. PubMed ID: 1458603
    [No Abstract]   [Full Text] [Related]  

  • 9. Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine/methamphetamine immunoassay.
    Papa P; Rocchi L; Mainardi C; Donzelli G
    Eur J Clin Chem Clin Biochem; 1997 May; 35(5):369-70. PubMed ID: 9189741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine.
    Apollonio LG; Whittall IR; Pianca DJ; Kyd JM; Maher WA
    J Anal Toxicol; 2007 May; 31(4):208-13. PubMed ID: 17555644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. I. Stereoselectivity and clinical evaluation.
    Poklis A; Hall KV; Eddleton RA; Fitzgerald RL; Saady JJ; Bogema SC
    Forensic Sci Int; 1993 Apr; 59(1):49-62. PubMed ID: 8505029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive results with Emit II amphetamine/methamphetamine assay in users of common psychotropic drugs.
    Smith-Kielland A; Olsen KM; Christophersen AS
    Clin Chem; 1995 Jun; 41(6 Pt 1):951-2. PubMed ID: 7768025
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine.
    Ruangyuttikarn W; Moody DE
    J Anal Toxicol; 1988; 12(4):229-33. PubMed ID: 2903272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of EMIT amphetamine immunoassays to urinary desoxyephedrine following Vicks inhaler use.
    Poklis A; Moore KA
    Ther Drug Monit; 1995 Feb; 17(1):89-94. PubMed ID: 7725384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of D,L-amphetamine, D,L-methamphetamine, and illicit amphetamine analogs using diagnostic products corporation's amphetamine and methamphetamine radioimmunoassay.
    Cody JT
    J Anal Toxicol; 1990; 14(5):321-4. PubMed ID: 1979827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 125I radioimmunoassay for the dual detection of amphetamine and methamphetamine.
    Ward C; McNally AJ; Rusyniak D; Salamone SJ
    J Forensic Sci; 1994 Nov; 39(6):1486-96. PubMed ID: 7815028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of the Emit II amphetamine/methamphetamine assay to specimens collected following use of Vicks inhalers.
    Poklis A; Jortani SA; Brown CS; Crooks CR
    J Anal Toxicol; 1993 Sep; 17(5):284-6. PubMed ID: 8107462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of designer drug cross-reactivity on five commercial immunoassay screening kits.
    Regester LE; Chmiel JD; Holler JM; Vorce SP; Levine B; Bosy TZ
    J Anal Toxicol; 2015 Mar; 39(2):144-51. PubMed ID: 25492523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multi-drug screening immunoassay: false positive result for methamphetamine].
    Aranda-Cárdenas MD; Iglesias-Lepine ML; Puiggalí-Ballart M; Skaf-Peters E
    Med Clin (Barc); 2006 Apr; 126(15):597. PubMed ID: 16756925
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine.
    D'Nicuola J; Jones R; Levine B; Smith ML
    J Anal Toxicol; 1992; 16(4):211-3. PubMed ID: 1501473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.